A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy

NCT05696613 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

148

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Membranous Nephropathy

Interventions

DRUG: SNP-ACTH (1-39) Gel
DRUG: Rituximab

Sponsor

Cerium Pharmaceuticals, Inc.